Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Drug Metabolism And Disposition

• Publication date

  2002-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/DMD.30.2.183PMID 11792689
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach

  2004cited by this paper
• Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms.

  2001influential reference
• Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.

  2001cited by this paper
• A complete kinetic study of GG versus AG plantination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species.

  2000cited by this paper
• Anticancer Activity of Cisplatin and Related Complexes

  1999cited by this paper
• Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.

  1999cited by this paper
• WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study

  1999cited by this paper
• Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol®) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography

  1998cited by this paper
• Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.

  1998cited by this paper
• Influence of amifostine on the pharmacokinetics of cisplatin in cancer patients.

  1998cited by this paper
• Pharmacokinetics of amifostine and its metabolites in patients.

  1997cited by this paper
• Kinetic analysis of the cis-diamminedichloroplatinum(II)--cysteine reaction: implications to the extent of platinum--DNA binding.

  1997influential reference
• Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient

  1996cited by this paper
• Cellular distribution and cellular reactivity of platinum (II) complexes.

  1996cited by this paper
• Platinum binding to metallothionein. Analysis of circular dichroism spectra of complexes formed between metallothionein and platinum from cis- and trans-diamminedichloroplatinum.

  1995cited by this paper
• Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.

  1995cited by this paper
• The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells.

  1994cited by this paper
• Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.

  1994cited by this paper
• Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.

  1993cited by this paper
• Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.

  1992cited by this paper
• High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

  1992cited by this paper
• Determination of the acid dissociation constants for WR-1065 by proton NMR spectroscopy.

  1992influential reference
• Mechanisms of resistance to cisplatin.

  1991cited by this paper
• Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate.

  1991cited by this paper
• DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).

  1991cited by this paper
• Metallothionein gene expression and resistance to cisplatin in human ovarian cancer

  1990cited by this paper
• Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.

  1990cited by this paper
• Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.

  1989cited by this paper
• The determination of platinum in biological materials by electrothermal atomic absorption spectroscopy

  1987influential reference
• Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.

  1987cited by this paper
• Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.

  1987influential reference
• Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

  1986cited by this paper
• Binding of cis-dichlorodiammine platinum(II) to metallothionein in Ehrlich cells.

  1985influential reference
• Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).

  1982cited by this paper
• Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds.

  1981cited by this paper
• Rates of thiol-disulfide interchange reactions involving proteins and kinetic measurements of thiol pKa values.

  1980influential reference
• DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity.

  1979cited by this paper
• Studies on the biosynthesis of the chondroitin sulfate-protein linkage region.

  1968cited by this paper

• N-Acetylcysteine Role in Maintaining Renal Function in Cancer Patients with Cisplatin-Based Chemotherapy

  2025cites this paper
• Enhanced pyroptosis induction with pore-forming gene delivery for osteosarcoma microenvironment reshaping

  2024cites this paper
• Nucleic Acid-based Electrochemical Sensors Facilitate the Study of DNA Binding by Platinum (II)-based Antineoplastics.

  2024cites this paper
• Black tea bioactive phytoconstituents realign NRF2 for anticancer activity in lung adenocarcinoma

  2023cites this paper
• Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target?

  2023cites this paper
• A review: Systematic research approach on toxicity model of liver and kidney in laboratory animals

  2022cites this paper
• Pyridine derivative platinum complexes: Synthesis, molecular structure, DFT and initial anticancer activity studies

  2021cites this paper
• Demonstration of the protective effect of ghrelin in the livers of rats with cisplatin toxicity

  2021cites this paper
• Enolate-forming compounds provide protection from platinum neurotoxicity.

  2020cites this paper
• Pathological Role of Unsaturated Aldehyde Acrolein in Diabetic Retinopathy

  2020cites this paper
• New insights into the protection of growth hormone in cisplatin-induced nephrotoxicity: The impact of IGF-1 on the Keap1-Nrf2/HO-1 signaling.

  2020cites this paper
• Chlorella sorokiniana Extract Prevents Cisplatin-Induced Myelotoxicity In Vitro and In Vivo

  2020cites this paper
• Modeling of drug delivery and transport during intraperitoneal chemotherapy

  2019cites this paper
• Effect of selenium and nano-selenium on cisplatin-induced nephrotoxicity in albino rats

  2019cites this paper
• Modeliranje elektroporacije na več ravneh

  2019cites this paper
• 9 Summary and Concluding Discussion

  2018cites this paper
• Two-photon imaging of the endoplasmic reticulum thiol flux in the brains of mice with depression phenotypes.

  2018cites this paper
• Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine

  2018cites this paper
• Citrullus colocynthis Linn. Fruit extract ameliorates cisplatin-induced hepato-renal toxicity in rats

  2018cites this paper
• Construction and Electrochemical Property Studies of DNA Duplexes Tethered to Gold Electrode via Au−C Bond

  2018cites this paper
• Capturing platinum in cisplatin: kinetic reactions with recombinant human apo-metallothionein 1a.

  2018cites this paper
• Connecting the in vitro and in vivo experiments in electrochemotherapy ‐ a feasibility study modeling cisplatin transport in mouse melanoma using the dual‐porosity model

  2018cites this paper
• N‐acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity

  2018cites this paper
• AMIFOSTINE ( WR 2721 ) CONFERS DNA PROTECTION TO IN VIVO CISPLATIN-TREATED MURINE PERIPHERAL BLOOD LEUKOCYTES

  2017cites this paper
• Cisplatin resistance in cell models: evaluation of metallomic and biological predictive biomarkers to address early therapy failure.

  2017cites this paper
• Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines

  2017cites this paper
• Sinapic acid modulates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats.

  2017cites this paper
• Modelling drug transport during intraperitoneal chemotherapy

  2017cites this paper
• Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance.

  2016cites this paper
• ASCORBIC ACID (VITAMIN C) AMELIORATES CISPLATIN- INDUCED HEMATOTOXICITY IN TUMOR-BEARING MICE

  2016cites this paper
• A molecular assembly that crawls on a solid substrate with a metabolic-like process

  2016cites this paper
• Influence of Renal ABC and SLC Transporter Polymorphisms on Cisplatin-induced Nephrotoxicity in Patients with Esophageal Cancer

  2016cites this paper
• Beneficial Effects of Hesperidin against Cisplatin-Induced Nephrotoxicity and Oxidative Stress in Rats

  2015cites this paper
• Research Article Beneficial Effects of Hesperidin against Cisplatin-Induced Nephrotoxicity and Oxidative Stress in Rats

  2015cites this paper
• Biochemical changes associated with ascorbic acid–cisplatin combination therapeutic efficacy and protective effect on cisplatin-induced toxicity in tumor-bearing mice

  2015cites this paper
• In vitro effects of platinum compounds on renal cellular respiration in mice.

  2015cites this paper
• Date (Phoenix dactylifera) Polyphenolics and Other Bioactive Compounds: A Traditional Islamic Remedy’s Potential in Prevention of Cell Damage, Cancer Therapeutics and Beyond

  2015cites this paper
• Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.

  2015cites this paper
• New use of metals as nanosized radioenhancers.

  2014cites this paper
• Amelioration of cisplatin-induced nephrotoxicity by grape seed extract and fish oil is mediated by lowering oxidative stress and DNA damage

  2014cites this paper
• In Vitro Metabolism and Drug-Drug Interaction Potential of UTL-5g, a Novel Chemo- and Radioprotective Agent

  2014cites this paper
• Preclinical high‐dose acetaminophen with N‐acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid tumors

  2014cites this paper
• The protective effect of selenium in cisplatin-related retinotoxicity

  2014cites this paper
• Nitrite and nitrate concentrations and metabolism in breast milk, infant formula, and parenteral nutrition.

  2014cites this paper
• Abrogation by Curcumin on Testicular Toxicity Induced by Cisplatin in Rats

  2014cites this paper
• EffectofLow RadiationDose on Cisplatin Induced Hepato-TesticularDamage in Male Rats

  2014cites this paper
• Measuring DNA damage and associated epigenetic changes genome-wide in cells following exposure to platinum analogue chemotherapeutic drugs

  2014cites this paper
• Possible protective effects of garlic, Ginkobiloba and silymarin on cisplatin hepatotoxicity in protein-malnourished rats.

  2014cites this paper
• Effect of Low Radiation Dose on Cisplatin Induced Hepato- Testicular Damage in Male Rats

  2014cites this paper
• Protective and Ameliorative Effects of Aloe vera Gel on Cisplatin Induced Oxidative Stress in Wistar Albino Rats

  2014cites this paper
• Synergistic Growth-Suppressive Effects of Quercetin and Cisplatin on HepG2 Human Hepatocellular Carcinoma Cells

  2013cites this paper
• Evaluation of drug-induced injury and human response in precision-cut tissue slices

  2013cites this paper
• The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin

  2013cites this paper
• Effect of cisplatin on glutathione redox status in isolated plasma and cytosolic fraction

  2013cites this paper
• The Protective Role of Neem Leaves Extract on Cisplatin-Induced Polysaccharides and Protein Depletion in Rat Liver and Kidney

  2013cites this paper
• Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines

  2012cites this paper
• Tannic acid mitigates cisplatin-induced nephrotoxicity in mice

  2012cites this paper
• Lipid Peroxidative Damage on Cisplatin Exposure and Alterations in Antioxidant Defense System in Rat Kidneys: A Possible Protective Effect of Selenium

  2012cites this paper
• Growth Factors and the Redox State as New Therapeutic Targets for Colorectal Cancer

  2012cites this paper
• Studies on the protective effect of flaxseed oil on cisplatin-induced hepatotoxicity

  2012cites this paper
• Subcellular targets of cisplatin cytotoxicity: an integrated view.

  2012cites this paper
• Studies on the protective effect of fish oil against cisplatin induced hepatotoxicity

  2011cites this paper
• Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats.

  2011cites this paper
• Specific effects of reactive thiol drugs on mitochondrial bioenergetics

  2011cites this paper
• Investigation of DNA adducts formed in cells and clinical tumour biopsies following exposure to platinum-containing anticancer drugs

  2011cites this paper
• Modeling the Cytotoxicity of Cisplatin

  2011cites this paper
• Analytical methodologies for metallomics studies of antitumor Pt-containing drugs.

  2010cites this paper
• Effects of cisplatin on lipid peroxidation and the glutathione redox status in the liver of male rats: The protective role of selenium

  2010cites this paper
• The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin

  2010cites this paper
• Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo.

  2010cites this paper
• Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1.

  2010cites this paper
• Novel insights into the bottom-up mass spectrometry proteomics approach for the characterization of Pt-binding proteins: The insulin-cisplatin case study.

  2010cites this paper
• Molecular origin of the sequence-dependent kinetics of reactions between cisplatin derivatives and DNA

  2009cites this paper
• Amifostine (WR2721) Confers DNA Protection to in Vivo Cisplatin-Treated Murine Peripheral Blood Leukocytes

  2009cites this paper
• The mechanism of action of platinum anticancer agents--what do we really know about it?

  2009cites this paper
• EXAFS structural study of platinum-based anticancer drugs degradation in presence of sulfur nucleophilic species.

  2009cites this paper
• Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts.

  2009cites this paper
• Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels.

  2008cites this paper
• Organ- and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs.

  2008cites this paper
• Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation

  2008cites this paper
• Desarrollo de métodos analíticos basados en técnicas cromatográficas y espectrometría de masas para estudios de metalómica de fármacos antitumorales de Pt en muestras biológicas

  2008cites this paper
• Evaluation of the Chemoprotective Role of N-Acetylcysteine on Cisplatin-Induced Nephrotoxicity: New Aspect of an Old Drug

  2008cites this paper
• Cisplatin-resistance and cell death in malignant pleural mesothelioma cells

  2008cites this paper
• Mathematical and Computational Modeling: Towards the Development and Application of Nanodevices for Drug Delivery

  2007cites this paper
• The role of sulfur in platinum anticancer chemotherapy.

  2007cites this paper
• New ways in RGD-peptide mediated drug targeting to angiogenic endothelium: On the nature of Drugs, Linkers, and Carriers

  2007cites this paper
• New ways in RGD-peptide mediated drug targeting to angiogenic endothelium : On the nature of drugs, linkers, and carriers.

  2007cites this paper
• Structural and mechanistic aspects of platinum anticancer agents

  2006cites this paper
• Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology.

  2006cites this paper
• Modification and Uptake of a Cisplatin Carbonato Complex by Jurkat Cells

  2006cites this paper
• Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand.

  2006cites this paper
• Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro

  2006cites this paper
• Synthesis of polyamines from ethylenediamine and their platinum(II) complexes, potential antitumor agents

  2006cites this paper
• The trans labilization of cis-[PtCl2(13CH3NH2)2] by glutathione can be monitored at physiological pH by [1H,13C] HSQC NMR

  2006cites this paper
• Redox regulation of RhoA.

  2006cites this paper
• Chemical, Pharmacokinetic and Biological Aspects of Platinum-Based Drugs

  2005cites this paper
• Analysis of cytotoxicities of platinum compounds

  2005cites this paper
• Biochemical and Proteomics Approaches to Characterize Topoisomerase IIα Cysteines and DNA as Targets Responsible for Cisplatin-Induced Inhibition of Topoisomerase IIα

  2005influential citation
• Kidney Slices of Human and Rat to Characterize Cisplatin-Induced Injury on Cellular Pathways and Morphology

  2004cites this paper
• No Correlation between GSH Levels in Human Cancer Cell Lines and the Cell Growth Inhibitory Activities of Platinum Diamine Complexes

  2004cites this paper